Capital Counsel’s Varex Imaging VREX Stock Holding History

Capital Counsel’s Portfolio VREX Stock Details VREX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-8,681	Closed	-$292K	–	62
2017 Q1	$292K	Buy	+8,681	New	+$275K	0.03%	54

Other funds holding VREX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

QV Investors Calgary, Alberta, Canada $1.3B AUM 31.14% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $20.5B AUM 26.83% 1-Year Est. Return

CWAM

Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bodenholm Capital Stockholm, Sweden $61.9M AUM 34.32% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Capital Counsel's VREX Position: Q2 2017 in Review

Capital Counsel sold out of Varex Imaging (VREX) in Q2 2017, closing a stake of 8,681 shares — an estimated $292K sold.

Capital Counsel first reported a position in VREX in Q1 2017 and held it in 1 quarter. The position peaked at $292K in Q1 2017. 274 funds tracked by Wall St. Rank hold VREX as of Q2 2017.

Capital Counsel reported no remaining Varex Imaging position as of Q2 2017 after selling out during the quarter.
Capital Counsel sold 8,681 Varex Imaging shares in Q2 2017, an estimated $292K.
Capital Counsel first reported a position in Varex Imaging in Q1 2017 and held it in 1 quarter.
Capital Counsel's Varex Imaging position peaked at $292K in Q1 2017.
274 funds tracked by Wall St. Rank held Varex Imaging as of Q2 2017.

Based on Capital Counsel's 13F filing for Q2 2017, filed 10 Aug 2017.